Imiquimod
NDC 0093-3133, imiquimod, cream, from Teva Pharmaceuticals USA, Inc..
- Product NDC
- 0093-3133
- Status
- Listed
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Dosage form
- CREAM
- Route
- TOPICAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA022483
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0093-3133 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IMIQUIMOD37.5 mg/g
Pharmacologic classes
Increased Cytokine Activity [PE]; Increased Cytokine Production [PE]; Interferon Inducers [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0093-3133-31 | 00093313331 | 1 BOTTLE, PUMP in 1 CARTON (0093-3133-31) / 7.5 g in 1 BOTTLE, PUMP |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/9f2cbefd-f295-47e2-8a9e-3e7c5812c963NADAC price for package 00093313331
GET /v1/drugs/nadac/00093313331
Use it
Look up 0093-3133 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0093-3133 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0093-3133. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.